19-13135341-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP2PP3_Moderate
The NM_052876.4(NACC1):c.134G>A(p.Arg45Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,334 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_052876.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NACC1 | NM_052876.4 | c.134G>A | p.Arg45Gln | missense_variant | 2/6 | ENST00000292431.5 | NP_443108.1 | |
NACC1 | XM_005259721.4 | c.134G>A | p.Arg45Gln | missense_variant | 3/7 | XP_005259778.1 | ||
NACC1 | XM_047438118.1 | c.134G>A | p.Arg45Gln | missense_variant | 2/6 | XP_047294074.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NACC1 | ENST00000292431.5 | c.134G>A | p.Arg45Gln | missense_variant | 2/6 | 1 | NM_052876.4 | ENSP00000292431.3 | ||
NACC1 | ENST00000586171.3 | c.134G>A | p.Arg45Gln | missense_variant | 3/7 | 5 | ENSP00000467120.2 | |||
NACC1 | ENST00000700232.1 | c.134G>A | p.Arg45Gln | missense_variant | 2/6 | ENSP00000514870.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461334Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726986
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 09, 2022 | Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with NACC1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 45 of the NACC1 protein (p.Arg45Gln). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 04, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.